RANDALL GEORGE NIXON, M.D. Diplomate, American Board of Urology



Similar documents
Comprehensive Adult & Pediatric Urology

ANDREW CALLAWAY JAMES, MD

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

1. What is the prostate-specific antigen (PSA) test?

The 4Kscore blood test for risk of aggressive prostate cancer

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

PSA screening: Controversies and Guidelines

Roy M. Dressner, DO, F.A.C.S, F.A.S.C.R.S

Curriculum Vitae. Name: Dr. Rodney B. Young, III M.D.

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

Assistant Professor Boca Raton, FL Exercise Science & Health Promotion Office: (561)

Gleason Score. Oncotype DX GPS. identified for. about surveillance. time to get sophisticated

Brian Louis Cohen, M.D., M.P.H.

Curriculum Vitae and Bibliography Amy C. Almaraz Nielsen, DO

PSA screening in asymptomatic men the debate continues keyword: psa

Colton B. Christian Department of Psychology 1227 University of Oregon Eugene, OR

The University of Georgia, Graduate Certificate in Gerontology ( )

IME/CME Scheduling Worksheet

Curriculum Vitae. Ovunc Bardakcioglu, M.D. Undergraduate degree and major, university and date

The 4Kscore blood test for risk of aggressive prostate cancer

MEDICAL STAFF DIRECTORY

Case Western Reserve University Cleveland, Ohio. Masters of Science in Anesthesia Case Western Reserve University School of Medicine

Saturation Biopsy for Diagnosis and Staging of Prostate Cancer. Original Policy Date

CURRICULUM VITAE. PRESENT TITLE: Associate Professor and Associate Director, Residency Program

Bladder cancer treatment decision, management, and psychosocial outcomes: Results of patients interviews

Combined Harvard Urologic Oncology Fellowship Program

CURRICULUM VITAE JAMES ALTON BURKS, JR, MD, MBA, FACS, RVT Enadia Way Van Nuys, CA 91406

CURRICULUM VITAE. JONATHAN J. MYER, M.D. Orthopaedic Surgeon

Todd Randall Wilcox, M.D., M.B.A., C.C.H.P.-A.

-Bowling Green State University, Bachelor of Arts and Bachelor of Science, The Ohio State University College of Medicine, graduated 1959.

CURRICULUM VITAE. Michele Toby Sasmor, M.D.

PERSONAL: Married - May 2, 1993 Wife - Lisa Lickstein, MBA, MSW Children - Haley, November 13, 1996; Nicole, June 26, 2000; Jessica, August 30, 2004

"Statistical methods are objective methods by which group trends are abstracted from observations on many separate individuals." 1

CURRICULUM VITAE. Alfonso Barnard Barragan, M.D. Suite 305 Monterey Park, CA (626)

TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER

Curriculum Vitae Gilda Edwards Ennis

Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery

2016 Mayo Clinic Urology Review

Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding

CURRICULUM VITAE. Jane/John G. Doe, M.D., Ph.D. Associate Professor of Medicine (and include Administrative Title) Division of Cardiovascular Medicine

Fundamentals of Spine Surgery and Interventional Pain Management

Curriculum Vitae Eric S. Miguelino, M.D. Staff Toxicologist, Department of Public Health, Food and Drug Branch, State of California

CURRICULUM VITAE. (b) (6) University of Oklahoma Health Sciences Center. Director of Clinical Research Unit Department of Dermaology

NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER

KELLI DEWITT WHITEHEAD, RN, MS, ARNP

Surveillance for Hepatocellular Carcinoma

June 2014 CURRICULUM VITAE. Peter E. Friedell, M. D. FACP S. Wabash Suite 203. Chicago, Illinois

MARGUERITE V. DEWITT, M.D., J.D.

Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?

Applicant Name: Please Print

Health Insurance Benefits for Treatment of Tobacco Dependence. Summary

Michael S. Zeide, M.D., F.A.C.S. Performance Orthopedics of the Palm Beaches 7593 Boynton Beach Boulevard, Suite 280 Boynton Beach, FL 33437

2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER

EDUCATION AND TRAINING

Jonathan Christian Yang M.D. C U R R I C U L U M V I T A E

MEDICAL STAFF DIRECTORY

Prostate Cancer. Treatments as unique as you are

Husam G. Elias MD DMD

Timothy DeRouen, Ph.D.

4/8/13. Pre-test Audience Response. Prostate Cancer Screening and Treatment of Prostate Cancer: The 2013 Perspective

MEDICAL STAFF DIRECTORY

Sarah A. Vlach, M.D. Curriculum Vitae Page 1

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

855-DRSAMADI or

W. Allen Moore, Jr., PT, PhD 1501 Lakeside Drive

ROGER E. MURKEN, MD. Curriculum Vitae. OrthoColorado Hospital W. 2 nd Place Lakewood, CO 80228

Radiation Therapy in Prostate Cancer Current Status and New Advances

CURRICULUM VITAE. Teresa A. Campbell, M.D. Mars Hill College, Mars Hill, NC B.S., Chemistry, 1980 Magna cum laude graduate

Outpatient Physical Therapy Locations

Bingsheng Teng 滕 斌 圣

Professional CV EDUCATION

Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology

What do you see as the priorities of the Nominating Committee in selecting the future leaders of our Academy?

R e z i n O r t h o p e d i c s a n d S p o r t s M e d i c i n e

Dawn M. Turnage, DNP, ARNP, FNP-BC

Precise, Minimally Invasive Prostate Cancer Removal

Official reprint from UpToDate UpToDate

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward

Prostate Cancer Screening in Taiwan: a must

The PLCO Trial Not a comparison of Screening vs no Screening

Welcome Summer Interns

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer

Treating Prostate Cancer

Does my patient need more therapy after prostate cancer surgery?

PSA: Prostate Cancer Screening

Joseph M. Ihm, MD EDUCATION GRADUATE MEDICAL EDUCATION. BOARD CERTIFI CATION and MEDICAL LICENSURE FACULTY APPOINTMENTS HOSPITAL APPOINTMENTS

CURRICULUM VITAE. 900 Rand Road suite 120 Des Plaines, IL (O) (847) (F) (847)

Role of MRI in the Diagnosis of Prostate Cancer, A Proposal

CURRICULUM VITA. JULIA A. SMITH, Ph.D. Associate Professor Division of Special Education Undergraduate and Graduate Faculty Appointed 1985

Radiation Therapy in Prostate Cancer Current Status and New Advances

SPECIALTY: Plastic and Reconstructive Surgery. Harvard College, A.B., 1959 University of Colorado School of Medicine, M.D., 1963

CURRICULUM VITAE. 9/61 to 6/62 Pre-Med Kansas State Teachers College Emporia, KS

Melissa A. Jurkiewicz Assistant Professor College of Education, MS 280 University of Nevada, Reno

Janki Gandhi, PA-C Physician Assistant

Curriculum Vitae. New York Medical College M.D., 1980

GERARD MICHAEL NOLAN, M.D., F.A.C.S.

John Andrew Hansen Department of Criminology and Criminal Justice Western Carolina University Belk 410-G Cullowhee, NC

DAVID KEITH JONES. December 10, 1962; Santa Monica, CA. Marital Status: Married to Marjorie Kathleen Smith: October 6, 2002

George J. Hruza, MD, MBA Laser and Dermatologic Surgery Center (St. Louis University) 1001 Chesterfield Parkway East Suite 101 Chesterfield, MO 63017

Transcription:

RANDALL GEORGE NIXON, M.D. Diplomate, American Board of Urology EDUCATION / INDEPENDENT STUDIES 2002 6/30/03 Vanderbilt University Medical Center Chief Resident, Department of Urologic Surgery Nashville, Tennessee 1999-2002 Vanderbilt University Medical Center Resident, Department of Urologic Surgery Nashville, Tennessee 1998-1999 Vanderbilt University Medical Center Intern, Department of General Surgery Nashville, Tennessee 1995-1998 University of Washington School of Medicine (M.D.) Seattle, Washington 1995-1996 University of Washington School of Medicine Independent Year of Prostate Cancer Research Mentor: Michael K. Brawer, M.D. 1993-1995 University of Nevada School of Medicine (transferred) Reno, Nevada 1992-1993 Volunteer Work, Hospital Bayan, Palacios, Honduras 1988-1992 Pacific University (B.S.) Forest Grove, Oregon LICENSURE: 12/02 present 10377 Nevada Medical License 3/03 present A82439 California Medical License

Randall G. Nixon, M.D. Page 2 BOARD CERTIFICATION: 2/28/05 2/28/15 American Board of Urology HONORS/AWARDS College Graduated with University Honors, Cum Laude All-District and All-Conference Golfer Scholar Athlete of the Year, 1992 Three-Time Participant in the NAIA National Golf Championship Sigma Xi Scientific Research Award Beta Beta Beta Honors Biology Award American Heart Association Summer Research Fellowship, Division of Cardiology, Oregon Health Sciences University Medical School Vice President of First Year Medical School Class, University of Nevada School of Medicine Urology Research Grant, Awarded by The Swedish Foundation, Swedish Medical Center, Seattle, Washington PROFESSIONAL MEMBERSHIPS American Urological Association, Member, 1999 present Southeastern Section of the American Urological Association, Candidate Member, 1999 2003 Western Section of the American Urological Association, Member, 2003 present American Association of Clinical Urologists, Member, 2002 present American Medical Association, Member, 1998 present

Randall G. Nixon, M.D. Page 3 PROFESSIONAL APPOINTMENTS Staff Urologist, Carson Tahoe Hospital, 8/2003 present Staff Urologist, Barton Memorial Hospital, 9/2003 present Staff Urologist, Sierra Surgery & Imaging 8/2003 - present (Formerly Carson Ambulatory Surgery Center, Incorporated ) Staff Urologist, South Lyon Medical Center, 8/2003 present PUBLICATIONS ORIGINAL CONTRIBUTIONS 1. Nixon RG, Lilly JD, Liedtke RJ, Batjer JD: Variation of free and total prostatespecific antigen levels: The effect on the percent free/total PSA. Arch Path Lab Med. 1997; 121: 385-391. 2. Nixon RG, Wener MH, Smith KM, Parson RE, Strobel SA, Brawer MK: Biological variation of prostate-specific antigen levels in serum: An evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol. 1997; 157: 2183-2190. 3. Nixon RG, Wener MH, Smith KM, Parson RE, Blase AB, Brawer MK: Day to day changes in free and total PSA: significance of biological variation. Prostate Cancer and Prostatic Disease. 1997; 1: 90-96. 4. Nixon RG, Blase AB, Petteway JC, Meyer GE, Gold MH, Brawer MK: Comparison of three investigative assays for the free form of prostate-specific antigen in serum. J Urol. 1998; 160: 420-425. 5. Nixon RG, Meyer GE, Brawer MK: Difference in prostate size between patients from University and Veterans Affairs Medical Center populations. Prostate. 1999; 38: 144-150. 6. Nixon RG, Chang SS, Lafleur BJ, Smith JA, Cookson MS: Carcinoma-in-situ and tumor multifocality predict risk of prostatic urethral involvement at time of radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol. 2002; 167: 502-505.

Randall G. Nixon, M.D. Page 4 7. Nixon RG, Pope JC, Adams MC, Brock JW: Laparoscopic variability of the internal inguinal ring: review of the anatomic variation among children with and without a patent processus vaginalis. J Urol. 2002; 167: 1818-1820. 8. Smith JA, Nixon RG, Bueschen AJ, Venable DD, Henry HH: Impact of blinded versus unblinded abstract review on scientific program content. J Urol. 2002; 168: 2123-2125. 9. Nixon RG, O Connor JL, Milam DF: Efficacy of shunt surgery for refractory lowflow priapism: A report of the incidence of failed detumescence and erectile dysfunction. J Urol. 2003; 170:883-886. 10. Pope JC, Nixon RG, Adams MC, Brock JW,: The use of 2-octyl-cyanoacrylate (Dermabond) for childhood penile surgery: The initial experience. (Submitted to J Urol). REVIEW ARTICLES 11. Nixon RG, Brawer MK: PSA Testing: Continuing efforts to improve clinical usefulness. Mediguide Urol. 1996; 9(2): 1-6. 12. Nixon RG, Brawer MK: Enhancing the specificity of prostate-specific antigen: an overview of PSA density, PSA velocity, and age-specific PSA reference ranges. Brit J Urol. 1997; 79(Suppl. 1): 61-67. BOOK CHAPTERS 13. Nixon RG, Brawer MK: Refinements in serum PSA testing for the diagnosis of prostate cancer. Recent Advances in Urology. O Leary MP and Kirby R - editors. Churchill Livingston Publishers, London, 1996. ABSTRACTS Western Section American Urological Association, San Diego, CA, July 28, 1996 1. Nixon RG, Lilly JD, Batjer JD, Liedtke RJ, Hancock M, Brawer MK: Biological variability of serum free PSA levels. 2. Nixon RG, Lilly JD, Batjer JD, Liedtke RJ: Prospective comparison between the diagnostic performance of PSA velocity and free-to-total PSA ratio. Western Society for Clinical Investigation, Carmel, CA, February 7, 1997 1. Nixon RG, Wener MH, Strobel SA, Smith KM, Parson RE, Brawer MK: Biologic variation of free, total, and percent free/total prostate-specific antigen levels. American Urological Association Annual Meeting, New Orleans, LA, April 13, 1997 1. Nixon RG, Wener MH, Strobel SA, Smith KM, Parson RE, Brawer MK: Biological variation of free prostate-specific antigen levels in serum.

Randall G. Nixon, M.D. Page 5 2. Nixon RG, Petteway JC, Meyer GE, Brawer MK: Comparison of three investigative assays for the free form of prostate-specific antigen. The Society of Laparoendoscopic Surgeons Annual Meeting, Orlando, FL, Dec. 7, 2000 1. McDougall EM, Nixon RG, Deal KI, Nagy JM: Hand-Assisted Laparoscopic Right Nephroureterectomy Using the Intromit Device, (VIDEO). Southeastern Section American Urological Association, New Orleans, LA, March 31, 2001 1. Nixon RG, Chang SS, Cookson MS, Alberts GL, Dutta SC, Smith JA, Jr.: Predicting risk of urethral involvement after radical cystectomy in patients with muscle invasive transitional cell carcinoma of the bladder. 2. Nixon RG, Alberts GL, Cookson MS, Smith JA, Jr.: Prostate-sparing cystectomy and orthotopic neobladder for muscle invasive bladder cancer: reduced morbidity for younger patients with low risk of urethral involvement. 3. Nixon RG, Pope JC, Adams MC, Brock JW: Laparoscopic variability of the internal inguinal ring: review of the anatomic variation among children with and without a patent processus vaginalis. 4. Alberts GL, Nixon RG, McDougall EM: Hand-assisted nephroureterectomy for transitional cell cancer the Vanderbilt experience. 5. McDougall EM, Nixon RG, Deal KI, Nagy JM: Hand-Assisted Laparoscopic Right Nephroureterectomy Using the Intromit Device, (VIDEO). American Urological Association Annual Meeting, Los Angeles, CA, June 2, 2001 1. Nixon RG, Chang SS, Alberts GL, Dutta SC, Smith JA, Jr., Cookson MS: Predicting risk of urethral involvement after radical cystectomy in patients with muscle invasive transitional cell carcinoma of the bladder. 2. Parekh DJ, Nixon RG, Gilbert WB, Chang SS, Cookson MS, Smith JA, Jr.: Continent neobladder versus ileal conduit: A comparison of long-term morbidity and mortality. 3. McDougall EM, Nixon RG, Deal KI, Nagy JM: Hand-Assisted Laparoscopic Right Nephroureterectomy Using the Intromit Device, (VIDEO). Southeastern Section American Urological Association, Naples, FL, February 28, 2002 1. Nixon RG, Milam DF: Efficacy of surgical techniques for the treatment of low-flow priapism. American Urological Association Annual Meeting, Orlando, FL, May 28, 2002 1. Nixon RG, Pope JC, Adams MC, Brock JW: Laparoscopic variability of the internal inguinal ring: review of the anatomic variation among children with and without a patent processus vaginalis. 2. Alberts GL, Nixon RG, Chang SS, Cookson MS, Smith JA, Jr.: Ileal conduit urinary diversion in patients with previous history of abdominal / pelvic irradiation: A review of 36 patients.

Randall G. Nixon, M.D. Page 6 American Academy of Pediatrics Annual Meeting, Boston, MA, October 21, 2002 1. Nixon RG, Graves L, Adams MC, Brock JW, Pope JC: The use of 2-octylcyanoacrylate (Dermabond) for childhood penile surgery: The initial experience. MANUSCRIPT REVIEWS 1. Ad Hoc Reviewer for Clinical Chemistry and Laboratory Medicine, Manuscript 64/98: Analytical issues on prostate-specific antigen in relation to prostate cancer screening. April, 1998.